Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Central to this year's World Alzheimer's Day campaign is the active participation of people with dementia

Central to this year's World Alzheimer's Day campaign is the active participation of people with dementia

Research may provide a better understanding of the mental retardation observed in Cri-du-Chat Syndrome

Research may provide a better understanding of the mental retardation observed in Cri-du-Chat Syndrome

Dementia is set to become one of the greatest health challenges for the Australian community

Dementia is set to become one of the greatest health challenges for the Australian community

Immunoglobulins may help patients with Alzheimer’s

Immunoglobulins may help patients with Alzheimer’s

Inflammation could have important implications for modern-day health care

Inflammation could have important implications for modern-day health care

Protein that causes juvenile Batten disease also plays a key role in normal cell function

Protein that causes juvenile Batten disease also plays a key role in normal cell function

Immunoglobulins might be promising treatment for Alzheimer's disease

Immunoglobulins might be promising treatment for Alzheimer's disease

California Chamber of Commerce lends support to stem cell research

California Chamber of Commerce lends support to stem cell research

People with mild Alzheimer’s were more likely to make driving errors

People with mild Alzheimer’s were more likely to make driving errors

Statistical method for faster prognosis of Alzheimer’s and Parkinson’s diseases

Statistical method for faster prognosis of Alzheimer’s and Parkinson’s diseases

Higher blood levels of homocysteine may be associated with changes in deep brain tissue in middle-aged men

Higher blood levels of homocysteine may be associated with changes in deep brain tissue in middle-aged men

New study will examine why people live exceptionally long lives

New study will examine why people live exceptionally long lives

Discovery of way to regulate brain blood could lead to new treatments for stroke, migraine, Alzheimer’s

Discovery of way to regulate brain blood could lead to new treatments for stroke, migraine, Alzheimer’s

Transthyretin discovery may halt progression of Alzheimer's

Transthyretin discovery may halt progression of Alzheimer's

Studies of human genetic variation have found strong evidence for the action of natural selection

Studies of human genetic variation have found strong evidence for the action of natural selection

More than one billion people will be over 60 years old by 2025

More than one billion people will be over 60 years old by 2025

Drinking alcohol regularly in your 40's increases risk of mild cognitive impairment

Drinking alcohol regularly in your 40's increases risk of mild cognitive impairment

Omega-3 supplement may help protect against Alzheimer's

Omega-3 supplement may help protect against Alzheimer's

Scientists discover breakthrough method to treat neuronal diseases

Scientists discover breakthrough method to treat neuronal diseases

Two new findings in the field of primary prevention for dementia and Alzheimer’s disease

Two new findings in the field of primary prevention for dementia and Alzheimer’s disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.